18.3 Inspection, Closure, and Facility Discipline

Why a pharmacy has to be inspectable — and closeable

Quick Answer: CGS § 20-577 puts Drug Control inspectors in the field. Each retail pharmacy is inspected not less than once every four years. Institutional pharmacies may be inspected. To close, DCP requires 30 days’ notice to the Commission of Pharmacy (and to Drug Control and DEA if controlled substances remain). On closing day, prescription records go immediately to a nearby pharmacy, leftover CS go to another registrant, a reverse distributor, the vendor, or surrender, and the pharmacy license is returned. CGS § 20-579 can refuse, revoke, suspend, or condition the pharmacy license and assess up to $1,000 per Chapter 400j violation. CGS § 4-182(c) is the summary suspension path when public health, safety, or welfare imperatively requires emergency action.

NABP Competency 4.7.3–4.7.4 is operations at the end of the license: who walks in with a badge, how you wind up the files and the vault, and how the Commission hits the facility rather than only the pharmacist. Chapter 2 already placed inspectors in Drug Control, not in a Commission site visit. Chapter 5 already taught § 20-579 as the individual grounds list. This section asks the same statute to act on the license to operate a pharmacy.

Inspections — CGS § 20-577

The commissioner, not the Commission as a body, employs inspectors. Under § 20-577 they inspect pharmacies and other places in which drugs and devices are or may be dispensed or retailed, and they report violations of §§ 20-570 to 20-630, other drug and device laws, pharmacy licenses, nonlegend-drug permits, pharmacist licenses, and intern and technician supervision.

Two inspection cadences are tested:

• Retail pharmacy: the commissioner shall inspect each retail pharmacy not less than once every four years and shall develop a methodology to sample prescriptions dispensed by retail pharmacies for compliance with state dispensing laws. That four-year floor is current statute and matches Chapter 2. It is a minimum. A complaint, a sterile-compounding addendum, a CII perpetual-inventory problem, or a new-store opening inspection can put Drug Control in the store sooner.
• Institutional pharmacy and dispensing outpatient facility: the commissioner may inspect and may take steps the commissioner considers appropriate to correct deficiencies. “May” is not “never.” It is also not the retail shall / four-year sentence. Do not answer a hospital-pharmacy stem with “Drug Control is barred until year four.”

The commissioner also inspects correctional and juvenile training institutions and care-giving institutions for drug handling. Those visits are still Drug Control work.

Inspectors will ask for the posted pharmacy license, the DCP signage set from section 18.1, the pharmacist manager’s posted name, hours, the CII perpetual inventory, technician ratios, and — if you compound — the USP manuals from Chapter 17. Refusing a § 20-577 inspector because “only the Commission can inspect” is the Chapter 2 trap restated as a facility item.

Closure — DCP’s November 18, 2025 page

DCP’s Temporary or Permanent Pharmacy Closing guidance (updated November 18, 2025) is the operational checklist Connecticut pharmacists actually follow. Any pharmacy licensed in Connecticut that intends to close temporarily or permanently must give the Commission of Pharmacy notice of that intent thirty days prior to closing. If the pharmacy has controlled-substance stock, it must give the same 30-day notice to the Drug Control Division and to DEA.

On the day of closing:

• Immediately make prescription records available to a nearby pharmacy and post notice of that availability on the closed pharmacy’s window or door.
• If CS stock remains, take a physical inventory of all controlled-substance stock on hand.
• Transfer Schedule II stock using the purchasing DEA registrant’s DEA Form 222.
• Transfer all CS stock in a secure manner that minimizes loss.
• Unwanted CS may be returned to the vendor, transferred to a reverse distributor, or surrendered to Drug Control or DEA for disposal.

Representatives of the closed pharmacy must make these records available to Drug Control:

• unused DEA 222 forms;
• the current DEA registration;
• the current pharmacy license;
• the final controlled-substance inventory; and
• the green copy of the DEA 222 used to transfer Schedule II stock.

Keep, in an accessible manner for three years after the closing date, CS receipt records (completed 222s, invoices, logbooks) and CS disposition records (destructions, prescriptions, CIII–V refill logs, vendor returns). That three-year tail matches Connecticut’s ordinary CS retention, not the federal two-year floor.

Unscheduled short closures have a separate § 20-633h transfer-and-claim-reversal overlay; do not use that emergency-hours statute to skip a planned 30-day Commission notice. Do not box remaining oxycodone in the manager’s garage. Do not shred the prescription file because “the store is dark.” Remaining legend inventory that is still saleable goes to another pharmacy or an authorized reverse channel; remaining CS go only to a DEA registrant authorized to receive them.

Facility discipline versus the individual file — NABP 4.7.4

CGS § 20-579 is one statute with two targets. Chapter 5 taught it against the pharmacist license, temporary permit, intern registration, and technician registration. The same subsection expressly reaches a license to operate a pharmacy. The Commission may:

• refuse to authorize issuance or renewal of that pharmacy license;
• revoke, suspend, or place conditions on it; and
• assess a civil penalty of up to $1,000 per violation of any provision of Chapter 400j, or take other § 21a-7(7) action (reprimand, probation, fine).

Grounds that often show up as facility facts include an unsanitary premises (§ 20-579(a) sanitary-condition subdivision), USP <795> or <797> failures, permitting unlicensed practice, false representations, and incompetent or negligent operations. The Commission does not need a different “pharmacy-permit statute” to close a dirty store. It uses § 20-579 on the PCY credential while Drug Control writes the inspection.

Contrast the neighboring credentials so you do not grab the wrong section:

• Individual pharmacist — § 20-579 on the license to practice pharmacy (Chapter 5), plus § 20-605 unlicensed practice and § 20-581 criminal penalty when no other penalty is provided.
• Pharmacy (facility) — § 20-579 on the license to operate a pharmacy.
• Nonresident certificate — CGS § 20-629 lets the Commission deny, revoke, or suspend the certificate for failure to comply with §§ 20-627 to 20-630 and related grounds, including disciplinary action by any state or federal agency.
• Nonlegend permit — § 20-580 revocation or suspension.
• Wholesale — § 21a-70 is a DCP registration with its own denial and revocation path, not a Commission pharmacy license.

Summary action is the emergency overlay. CGS § 4-182(c) (Uniform Administrative Procedure Act) provides that if the agency finds that public health, safety, or welfare imperatively requires emergency action, and incorporates that finding in its order, summary suspension of a license may be ordered pending proceedings for revocation or other action. That is how a pharmacy that is an immediate danger comes off the street before a full contested hearing finishes. It is not a substitute for notice and a later hearing, and it is not a Commission member changing the locks without an agency order. Ordinary discipline still runs through DCP investigation, Commission hearing, and a proposed final decision the Commissioner of Consumer Protection must approve, modify, or reject (§ 21a-7), as Chapter 5 taught.

§ 20-594(f) feeds that file: report administrative or legal action against the pharmacy within ten business days. A sterile-compounding pharmacy has additional five-business-day reporting under § 20-633b(i). Missing the report is its own problem even if the underlying out-of-state case is later defended.

Realistic Connecticut scenarios

A Drug Control inspector arrives at a West Haven retail pharmacy in year two of a four-year cycle after a CII perpetual-inventory complaint. The manager cites the four-year sentence and refuses entry. The four-year clause is a minimum inspection cycle, not a shield. § 20-577 inspectors inspect pharmacies; a complaint visit is lawful.

A Bristol independent plans to close in ten days, shreds hard-copy prescriptions “for HIPAA,” and tells the manager to drive leftover oxycodone home until a reverse distributor “has a slot next month.” That plan fails the 30-day Commission (and DEA/Drug Control) notice, the nearby-pharmacy file handoff, the posted door notice, the CS inventory, and the reverse-distributor / 222 / surrender chain. HIPAA does not authorize destruction of a prescription file a nearby pharmacy needs to continue care.

The Commission finds a pharmacy operating without a pharmacist manager and with an unsanitary prescription department. It may suspend or revoke the pharmacy license and assess up to $1,000 per Chapter 400j violation under § 20-579. If the conditions imperatively threaten public safety, § 4-182(c) supports summary suspension pending the full revocation proceeding. Disciplining the pharmacist personally is a parallel file, not a requirement before the facility license can be touched.

Official anchors

• CGS § 20-577 — Drug Control inspectors; retail four-year cycle; institutional may inspect.
• DCP Temporary or Permanent Pharmacy Closing (November 18, 2025) — 30-day notice; nearby-pharmacy files; reverse distributor / 222 / license return.
• CGS § 20-579 — facility and individual sanction menu; $1,000 civil penalty.
• CGS § 20-629 — nonresident certificate discipline.
• CGS § 4-182 — UAPA summary suspension when public health, safety, or welfare imperatively requires emergency action.